Opportunity
Federal Register #2026-21470
NIH Center for Scientific Review closed virtual biomedical research review meetings
Buyer
Department of Health and Human Services — National Institutes of Health
Posted
October 21, 2026
Identifier
2026-21470
The National Institutes of Health’s Center for Scientific Review is announcing closed virtual review meetings for biomedical grant applications and one set of contract proposals. - Government buyer: U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), Center for Scientific Review (CSR); review panels are Special Emphasis Panels. - Review topics: BRAIN Initiative recording and modulation research; shared and basic instrumentation; NIH conference support; neuropharmacology; immunotherapeutics and biological therapeutics; cancer biotherapeutics and immunotherapy; cardiovascular and pulmonary career development; advanced therapeutics; international research collaborations; medical imaging, surgical sciences, and bioengineering; biomarkers, diagnostics, and disease therapy; macromolecular biophysics and biochemistry; applied immunology; biologic-based therapeutics for neurodegenerative disorders; anti-infective therapeutics; AIDS and mental health; infectious diseases and immunology; Common Fund data sets; gastroenterology, hepatology, and nutrition; and translational toxicology chemistry. - Purpose: Panels will evaluate grant applications; one panel will review contract proposals. No specific products, services, quantities, part numbers, or vendors are identified. - Notable requirement: Meetings are closed to protect confidential commercial information and personal information.
Description
The National Institutes of Health Center for Scientific Review gives notice of closed meetings of its Special Emphasis Panels. The panels will review and evaluate grant applications, and, for one meeting, contract proposals. The listed meetings take place virtually at the NIH Rockledge II location in Bethesda, Maryland, from November 12 through November 17, 2026. They are closed to the public because discussions may disclose confidential commercial information or personal information.